Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome Sequencing

References

• WHO. Global priority list of antibioticresistant bacteria to guide research, discovery, and development of new antibiotics. 2018.
   Google Scholar
• Irvem A. Colistin-daptomycin, colistin-linezolid, colistin-vancomycin combination effects on colistin in multi-resistant Acinetobacter baumannii strains. Medical Science and Discovery. 2018;5:124–129. doi:10.17546/msd.391234
   Google Scholar
• Lucas DD, Crane B, Wright A, et al. Emergence of high-level colistin resistance in an Acinetobacter baumannii clinical isolate mediated by inactivation of the global regulator H-NS. Antimicrob Agents Chemother. 2018;62:e02442–17. doi:10.1128/AAC.02442-1729712662
   PubMed Web of Science ®Google Scholar
• Evans BA, Amyes SGB. OXA β-lactamases. Clin Microbiol Rev. 2014;27:241–263. doi:10.1128/CMR.00117-1324696435
   PubMed Web of Science ®Google Scholar
• Amine A, Hazzah W, Abou-bakr A. Genetic background of carbapenem resistant Acinetobacter baumannii in a health care setting in Alexandria, Egypt. Bull High Inst Public Heal. 2011;41:311–324.
   Google Scholar
• Lee J, Chung ES, Ko KS. Transition of colistin dependence into colistin resistance in Acinetobacter baumannii. Sci Rep. 2017;7:14216. doi:10.1038/s41598-017-14609-029079752
   PubMed Web of Science ®Google Scholar
• Bahador A, Farshadzadeh Z, Raoofian R, Mokhtaran M, Pourakbari B. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation. Ann Clin Microbiol Antimicrob. 2018;17:24. doi:10.1186/s12941-018-0277-629859115
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Morand S, Rolain J. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643. doi:10.3389/fmicb.2014.0064325505462
   PubMed Web of Science ®Google Scholar
• Beceiro A, Llobet E, Aranda J, et al. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii by the pmrAB two-component regulatory system. Antimicrob Agents Chemother. 2011;55:3370–3379. doi:10.1128/AAC.00079-1121576434
   PubMed Web of Science ®Google Scholar
• Nhu NTK, Riordan DW, Nhu TDH, et al. The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications. Sci Rep. 2016;6(1):28291. doi:10.1038/srep2829127329501
   PubMed Web of Science ®Google Scholar
• Mu X, Wang N, Li X, et al. The effect of colistin resistance-associated mutations on the fitness of Acinetobacter baumannii. Front Microbiol. 2016;7:1715. doi:10.3389/fmicb.2016.0171527847502
   PubMed Web of Science ®Google Scholar
• Partridge SR, Di Pilato V, Doi Y, et al. Proposal for assignment of allele numbers for mobile colistin resistance (mcr) genes. J Antimicrob Chemother. 2018;73(10):2625–2630. doi:10.1093/jac/dky26230053115
   PubMed Web of Science ®Google Scholar
• Rebelo A, Bortolaia V, Kjeldgaard J, et al. Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes. Euro Surveill. 2018;23(6):17–00672. doi:10.2807/1560-7917.ES.2018.23.6.17-00672
   Google Scholar
• Rahman M, Ahmad S. 549. First report for emergence of chromosomal borne colistin resistance gene mcr-1 in a clinical acinetobacter baumannii Isolates from India. Open Forum Infect Dis. 2019;6(Supplement_2):S261–S262. doi:10.1093/ofid/ofz360.618
   Google Scholar
• Hameed F, Khan MA, Muhammad H, Sarwar T, Bilal H, Rehman TU. Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan. Rev Soc Bras Med Trop. 2019;52:e20190237. doi:10.1590/0037-8682-0237-201931508785
   PubMed Web of Science ®Google Scholar
• Martins-sorenson N, Snesrud E, Xavier D, et al. A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain. J Antimicrob Chemother. 2020;75(1):60–64. doi:10.1093/jac/dkz41331578567
   PubMed Web of Science ®Google Scholar
• Fam NS, Mohamed SH, Gamal D, Wasfy RM, Soliman M, El-Kholy AA. Reliability of phenotypic methods for detection of colistin resistance among carbapenem-resistant Acinetobacter baumannii clinical isolates from Egypt. Germs. 2020.
   Google Scholar
• Fam N, Gamal D, Salem D, Dahroug H, Wasfy RM, Morcos MM. Clonal diversity and high prevalence of Oxa-23 among carbapenem resistant Acinetobacter baumannii isolates in Egypt. J Biosci Appl Res. 2019;5:110–124.
   Google Scholar
• Fam N, Gamal D, Azmy M, et al. Antimicrobial efficacy of doripenem colistin combination on carbapenem - resistant Acinetobacter baumanii isolates by E-test Agar dilution and ultrastrastructural methods. Egypt J Med Microbiol. 2017;26(1):1–7. doi:10.12816/0046266
   Google Scholar
• Mohamed SH, Salem D, Azmy M, Fam NS. Antibacterial and antibiofilm activity of cinnamaldehyde against carbapenem-resistant Acinetobacter baumannii in Egypt: in vitro study. J Appl Pharm Sci. 2018;8:151–156. doi:10.7324/JAPS.2018.81121
   Google Scholar
• Nowak J, Zander E, Stefanik D, et al. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2017;72(12):3277–3282. doi:10.1093/jac/dkx32228961773
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI Supplement M100 2017.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI Supplement M100 2019.
   Google Scholar
• Fallah F, Noori M, Hashemi A, et al. Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica (Cairo). 2014;2014:245162.25133013
   PubMedGoogle Scholar
• Higgins PG, Prior K, Harmsen D, Seifert H. Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. PLoS One. 2017;12:e0179228.28594944
   PubMed Web of Science ®Google Scholar
• El-Sayed-Ahmed MA, Amin MA, Tawakol WM, Loucif L, Bakour S, Rolaina J-M. High Prevalence of blaNDM-1 carbapenemase-encoding gene and 16S rRNA armA methyltransferase gene among Acinetobacter baumannii clinical isolates in Egypt. Antimicrob Agents Chemother. 2015;59:3602–3605. doi:10.1128/AAC.04412-1425801566
   PubMed Web of Science ®Google Scholar
• Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genomics. 2019;5. doi:10.1099/mgen.0.000306
   Web of Science ®Google Scholar
• Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249–1260.30174448
   PubMed Web of Science ®Google Scholar
• Hua X, Liu L, Fang Y, et al. Colistin resistance in Acinetobacter baumannii MDR-ZJ06 revealed by a multiomics approach. Front Cell Infect Microbiol. 2017;7:45. doi:10.3389/fcimb.2017.0004528275586
   PubMed Web of Science ®Google Scholar
• EUCAST. The European committee on antimicrobial susceptibility testing. Breakpoint tables for interpretation of MICs and zone diameters. 2019 Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf.
   Google Scholar
• Abdulzahra AT, Khalil MAF, Elkhatib WF. First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt. New Microbes New Infect. 2018;26:53–58. doi:10.1016/j.nmni.2018.08.00730224972
   PubMedGoogle Scholar
• Singhal L, Sharma M, Verma S, et al. Comparative Evaluation of broth microdilution with polystyrene and glass-coated plates, agar dilution, E-Test, Vitek, and disk diffusion for susceptibility testing of colistin and polymyxin B on carbapenem-resistant clinical isolates of Acinetobacter baumannii. Microb Drug Resist. 2018;24:1082–1088. doi:10.1089/mdr.2017.025129406804
   PubMed Web of Science ®Google Scholar
• Bakthavatchalam YD, Veeraraghavan B, Shankar A, Thukaram B, Krishnan DN. Evaluation of colistin and polymyxin B susceptibility testing methods in Klebsiella pneumoniae and Acinetobacter baumannii. J Infect Dev Ctries. 2018;12:504–507. doi:10.3855/jidc.966031940304
   PubMed Web of Science ®Google Scholar
• Lai -C-C, Chen Y-S, Lee N-Y, et al. Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Infect Drug Resist. 2019;12:627–640.30936726
   PubMed Web of Science ®Google Scholar
• Çağlan E, Nigiz S, Sancak B, Gür D. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii. Acta Microbiol Immunol Hung. 2019;9:1–5. doi:10.1556/030.66.2019.021
   Web of Science ®Google Scholar
• Matuschek E, Åhman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect. 2018;24:865–870. doi:10.1016/j.cmi.2017.11.02029221995
   PubMed Web of Science ®Google Scholar
• Malli E, Tsilipounidaki K, Xitsas S, Pyridou P, Papagiannitsis C, Petinaki E. Implementation of the rapid polymyxin Acinetobacter test to detect colistin-resistant Acinetobacter baumannii. Microb Drug Resist. 2019.
   Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plésiat P. Resistance to polymyxins in gram-negative organisms. Int J Antimicrob Agents. 2017;49:526–535. doi:10.1016/j.ijantimicag.2016.11.02928163137
   PubMed Web of Science ®Google Scholar
• Ahmed SS, Alp E, Hopman J, Voss A. Global epidemiology on colistin resistant Acinetobacter baumannii. J Infect Dis Ther. 2016;4:1–5. doi:10.4172/2332-0877.1000287
   Google Scholar
• Snyman Y, Whitelaw A, Reuter S, Dramowski A, Reratilwe M, Maloba B. Clonal expansion of colistin resistant Acinetobacter baumannii isolates in Cape Town, South Africa. Int J Infect Dis. 2019.
   Web of Science ®Google Scholar
• Gerson S, Betts JW, Lucaßen K, et al. Investigation of novel pmrB and eptA mutations in isogenic Acinetobacter baumannii isolates associated with colistin resistance and virulence in vivo. Antimicrob Agents Chemother. 2019;63:e01586–18.30617096
   PubMed Web of Science ®Google Scholar
• Gerson S, Nowak J, Zander E, et al. Diversity of mutations in regulatory genes of resistance-nodulation- cell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2018;73:1501–1508. doi:10.1093/jac/dky08329554339
   PubMed Web of Science ®Google Scholar